FDA Inspection 1021337 — Rita M. Egan, M.D., Ph.D.

Rita M. Egan, M.D., Ph.D. — FEI 3013503592

The FDA completed an inspection of Rita M. Egan, M.D., Ph.D. on Aug 3, 2017 in Lexington, KY. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 2 citations were issued during this inspection. Product area: Drugs.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Aug 3, 2017
Fiscal Year
2017
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Lexington, KY (United States)

Additional details

Clinical Investigator (CI)

Citations

IDCFRDescription
756021 CFR 312.60FD-1572, protocol compliance
756221 CFR 312.60Informed consent

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.